-
Oil spill snarls shipping traffic in Antwerp port
-
Giving birth in a shelter in Israel
-
Five things to know about the planned Iran-US talks in Islamabad
-
Slot feels 'complete support' from Liverpool chiefs despite slump
-
Kyiv books tentative diplomatic coup with Iran war forays
-
Teenager shines as Britain seize control of BJK Cup tie with Australia
-
Chinese, Taiwanese will unite, Xi tells Taiwan opposition leader
-
Sleepy seal diverts traffic in Australian seaside town
-
Artemis astronauts to shed light on space health risks
-
Pakistan prepares to host US-Iran talks, as Lebanon fighting continues
-
Vaccine gaps fuel Bangladesh's deadly measles crisis
-
Fish furore fuels fierce election in India's West Bengal
-
Coachella kicks off with headliners Sabrina Carpenter, Bieber and Karol G
-
Myanmar junta chief sworn in as president
-
Exiled cartoonists give voice to Iran's silenced millions
-
In Pakistan's mediation to end Mideast war, China may hold the key
-
Knicks stay in hunt with late win over rival Celtics
-
'Sartorial diplomacy' on show in expo of late UK queen's fashion
-
Former Japan and AC Milan star Honda laces up boots again at 39
-
Stocks rally on optimism over Iran war ceasefire, oil extends gains
-
Lego-style memes troll Trump after fragile US-Iran truce
-
Chinese slimmers trade lost fat for beef
-
Jackson biopic shows franchise thriving despite abuse claims
-
New Jersey city spurns data center as defiance spreads
-
US box office looking good as cinema owners gather: industry chief
-
Firm Masters greens make life hard on golf's finest
-
Defending champ McIlroy shares Masters lead after back-nine birdie run
-
After oil, Venezuela opens up mining to private investors
-
Tigers' Meadows in hospital after colliding with teammate
-
US to host Israel-Lebanon talks as strikes threaten Iran ceasefire
-
'Scrappy' McIlroy leans on experience for share of Masters lead
-
Ukraine and Russia will cease fire for Orthodox Easter
-
Mateta inspires Palace win over Fiorentina in Conference League
-
Pioneering US hip-hop artist Afrika Bambaataa dies at 68
-
Russia bans Nobel-winning rights group, raids independent newspaper, in one day
-
Pentagon denies giving Vatican envoy 'bitter lecture'
-
Watkins propels Villa towards Europa League semis, Forest hold Porto
-
Aston Villa on verge of Europa League semis after beating Bologna
-
Venezuela police clash with protesters demanding salary rises
-
CAF president rejects corruption claims by Senegal
-
Israel and Lebanon set for ceasefire talks next week, says US official
-
US stocks extend gains, shrugging off ceasefire worries
-
IMF chief urges nations to 'do no harm' in fiscal response to Iran war
-
Sixers' Embiid to have surgery for appendicitis - team
-
Russian police raid independent Novaya Gazeta outlet, reporter detained
-
Former heavyweight king Fury adamant 'I've still got it' as Makhmudov awaits
-
Shipping toll for Hormuz passage sharply divides nations
-
McIlroy's back-nine birdie run grabs share of Masters lead
-
Melania Trump blasts 'lies' linking her to Epstein
-
'Anxious' Tatum back at Madison Square Garden with NBA East second seed on line
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
HACKENSACK, NJ / ACCESS Newswire / December 8, 2025 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and operational results for the second quarter ended October 31, 2025, on Monday, December 15, 2025, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EST (1:30 P.M. PST). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 691139. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 53331, or by accessing the investors section of the company's website within 72 hours.
About Champions Oncology, Inc.
Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.
Media Inquiries:
Gavin Cooper - Vice President, Global Marketing
[email protected]
Website: https://www.championsoncology.com/
Facebook: https://www.facebook.com/championsoncology/
LinkedIn: https://www.linkedin.com/company/champions-oncology-inc-/
Twitter: @ChampionsOncol1
Instagram: https://www.instagram.com/championsoncology/
SOURCE: Champions Oncology, Inc.
View the original press release on ACCESS Newswire
P.Hernandez--AT